Deadline: EOI 2pm (Eastern Time) 28 February 2018

Scope: The Saving Lives at Birth initiative was launched to find new tools and approaches to aid mothers and new-borns in poor, hard to reach communities during their most vulnerable hours. Six partners - USAID, the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, DFID, and KOICA - have come together to support this challenge.

Eligible applications will focus on any of the following areas alone or in combination:

  • Developing, testing and refining scaling plan/business model, including generating evidence of health outcomes or conducting further market research needed to engage partners
  • Transitioning to scale innovations with promising health impact and developed, sustainable scaling plans. These innovations must have demonstrated strong evidence in a controlled or limited setting of improved health outcome(s) and/or the reduction of significant barrier(s) to health and demand for the solution (i.e. proof of concept)

Applications are invited from organisations worldwide. Collaborations that involve diverse partnerships and multi-disciplinary/cross-sectoral teams are encouraged.

Funding: Round eight offers up to $400,000 USD for up to 24 months; and transition to scale funding of up $800,000 USD for up to 24 months. Co-funding and/or matched funding from partners is required, as this demonstrates a key stake in project success by project partners, as well as demand for the solution.

More Info:https://savinglivesatbirth.net/apply

Dear All,

 The Academy of Scientific Research and Technology (ASRT) in collaboration with several funding agencies in Europe and with support of European Commission, have announced the 6th call of proposals under JPI-AMR (Joint Programming Initiative on AntiMicrobial Resistance) to guide research, discovery, and development of new antibiotics (PPL). 

 This current call will only cover research tackling the bacterial pathogens and the resistances identified in the Global priority list of antibiotic-resistant bacteria published by the WHO in 2017 in addition to the multi- and extensively drug resistant Mycobacterium tuberculosis. It aims to address the identification and validation of new targets, compounds, or new tools. Projects considered for funding will involve fundamental and/or translation al research (One Health approach).

 Egyptian partners (or egyptian coordinators/PIs) in successful proposals addressing this call will be funded by the Academy of Scientific Research and Technology (ASRT).

 Consortia of eligible scientists could be from Belgium, Czech Republic, Egypt, Finland, France, Germany, Ireland, Italy, Latvia, Norway, Poland, Spain, Sweden and Switzerland.

* Consortia must include a minimum of three eligible partners from at least three different countries (the above-mentioned countries participating in the call), and a maximum of 6 project partners. Consortia exceeding 6 partners can be funded only if a partner from Egypt or Poland is included.

 For more information: https://www.jpiam r.eu/6thcall-now-open/ 

 

Go to top